Skip to main content
Top
Published in: Clinical Rheumatology 3/2007

01-03-2007 | Original Article

Oxidant/antioxidant status in men with Behçet’s disease

Authors: Seyithan Taysi, Berna Demircan, Necmettın Akdeniz, Mustafa Atasoy, Refik Ali Sari

Published in: Clinical Rheumatology | Issue 3/2007

Login to get access

Abstract

Behçet’s disease (BD) is a chronic, progressive disorder that affects many systems of the body including the eye. The aim of this study was to assess whether the increase in oxidative stress in the affected tissues is reflected by lipid peroxidation and to check for alterations in antioxidants and antioxidant enzyme activities in patients with BD. Erythrocyte antioxidant potential (AOP), glutathione (GSH) and GSH-dependent enzymes (glutathione peroxidase (GSH-Px), glutathione reductase (GRD) and glutathione-S-transferase (GST), catalase (CAT), Cu–Zn superoxide dismutase (Cu–Zn SOD) activities, malondialdehyde (MDA) and some trace elements (zinc, Zn; copper, Cu; manganese, Mn) levels in men with BD. Erythrocyte CAT, GSH-Px activities, MDA, GSH, AOP and serum Zn values were significantly lower in patients with BD than in the control group. However, erythrocyte Cu–Zn SOD, GRD activities, erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) and Cu values were significantly higher in patients with BD than in the control group, but GST activity and serum Mn values were unchanged. In conclusion, our results confirm the presence of oxidative stress in patients with BD and suggest that the severity of BD may arise from impaired antioxidant mechanisms. Therapy with antioxidants may lead to the increase in the antioxidant defense system and thus improvement in clinical symptoms.
Literature
1.
go back to reference Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/antioxidant status in serum of patients with Behçet’s disease. Ann Clin Lab Sci 32:377–382PubMed Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/antioxidant status in serum of patients with Behçet’s disease. Ann Clin Lab Sci 32:377–382PubMed
2.
go back to reference Behçet H (1937) Uber residivietende apththose, durch ein virus verursachte geschwura am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152–1157 Behçet H (1937) Uber residivietende apththose, durch ein virus verursachte geschwura am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152–1157
3.
go back to reference Watanabe K, Ohashi Y (1984) Natural killer cells activity in patients with Behcet’s disease. Am J Ophthalmol 98:813–814PubMed Watanabe K, Ohashi Y (1984) Natural killer cells activity in patients with Behcet’s disease. Am J Ophthalmol 98:813–814PubMed
4.
go back to reference Nussenblatt RB, Whitcup SM, Palestine AG (1996) Uveitis: fundamentals and clinical practice. Mosby, St. Louis, pp 334–353 Nussenblatt RB, Whitcup SM, Palestine AG (1996) Uveitis: fundamentals and clinical practice. Mosby, St. Louis, pp 334–353
5.
6.
go back to reference El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behçet’s disease in patients in the Sultanate of Oman; the significance of the antiphospholipid antibodies? Rheumatol Int 21:176–181PubMedCrossRef El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behçet’s disease in patients in the Sultanate of Oman; the significance of the antiphospholipid antibodies? Rheumatol Int 21:176–181PubMedCrossRef
7.
go back to reference Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G, Durmus B (1996) Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244:221–227PubMedCrossRef Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G, Durmus B (1996) Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244:221–227PubMedCrossRef
8.
go back to reference Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRef Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRef
9.
go back to reference Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status in serum of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688PubMedCrossRef Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status in serum of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688PubMedCrossRef
10.
go back to reference Yagi K (1984) Increased lipid peroxides initiates atherogenesis. Bio Essays 1:58–60 Yagi K (1984) Increased lipid peroxides initiates atherogenesis. Bio Essays 1:58–60
11.
12.
go back to reference Kose K, Yazici C, Cambay N, Ascioglu O, Dogan P (2002) Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet’s disease. Tohoku J Exp Med 197:9–16PubMedCrossRef Kose K, Yazici C, Cambay N, Ascioglu O, Dogan P (2002) Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet’s disease. Tohoku J Exp Med 197:9–16PubMedCrossRef
13.
go back to reference Aydin E, Sogut S, Ozyurt H, Ozugurlu F, Akyol A (2004) Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet’s disease with and without ocular disease. Ophthalmic Res 36:177–182PubMedCrossRef Aydin E, Sogut S, Ozyurt H, Ozugurlu F, Akyol A (2004) Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet’s disease with and without ocular disease. Ophthalmic Res 36:177–182PubMedCrossRef
14.
go back to reference Gul M, Kutay FZ, Temocin S, Hanninen O (2000) Cellular and clinical implications of glutathione. Indian J Exp Biol 38:625–634PubMed Gul M, Kutay FZ, Temocin S, Hanninen O (2000) Cellular and clinical implications of glutathione. Indian J Exp Biol 38:625–634PubMed
15.
go back to reference Saglam K, Serce AF, Yilmaz MI, Bulucu F, Aydin A, Akay C, Sayal A (2002) Trace elements and antioxidant enzymes in Behçet’s disease. Rheumatol Int 22:93–96PubMedCrossRef Saglam K, Serce AF, Yilmaz MI, Bulucu F, Aydin A, Akay C, Sayal A (2002) Trace elements and antioxidant enzymes in Behçet’s disease. Rheumatol Int 22:93–96PubMedCrossRef
16.
go back to reference Taysi S, Gülçin I, Sari RA, Kuskay S, Bakan N (2003) Trace elements and disease activity score in patients with rheumatoid arthritis. Pain Clin 4:435–439CrossRef Taysi S, Gülçin I, Sari RA, Kuskay S, Bakan N (2003) Trace elements and disease activity score in patients with rheumatoid arthritis. Pain Clin 4:435–439CrossRef
17.
go back to reference International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080 International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
18.
go back to reference Durak I, Karabacak HI, Buyukkocak S, Cimen MY, Kacmaz M, Omeroglu E, Ozturk HS (1998) Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 78:207–211PubMedCrossRef Durak I, Karabacak HI, Buyukkocak S, Cimen MY, Kacmaz M, Omeroglu E, Ozturk HS (1998) Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 78:207–211PubMedCrossRef
19.
go back to reference Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539–1543PubMed Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539–1543PubMed
20.
go back to reference Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500PubMed
21.
go back to reference Paglia DE, Valentina WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMed Paglia DE, Valentina WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMed
22.
go back to reference Pinto RE, Bartley W (1969) The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochem J 112:109–115PubMed Pinto RE, Bartley W (1969) The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochem J 112:109–115PubMed
23.
go back to reference Sen CK, Marin E, Kretzschmar M, Hänninen O (1992) Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization. J Appl Physiol 73:1265–1272PubMed Sen CK, Marin E, Kretzschmar M, Hänninen O (1992) Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization. J Appl Physiol 73:1265–1272PubMed
24.
go back to reference Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic, New York, pp 673–678 Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic, New York, pp 673–678
25.
go back to reference Tietze (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522PubMedCrossRef Tietze (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522PubMedCrossRef
26.
27.
go back to reference Kose K, Dogan P, Ascioglu M, Erkilic K, Ascioglu O (1995) Oxidative stress and antioxidant defenses in plasma of patients with Behcet’s disease. Tohoku J Exp Med 176:239–248PubMedCrossRef Kose K, Dogan P, Ascioglu M, Erkilic K, Ascioglu O (1995) Oxidative stress and antioxidant defenses in plasma of patients with Behcet’s disease. Tohoku J Exp Med 176:239–248PubMedCrossRef
28.
go back to reference Kose K, Yazici C, Assioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet’s disease. Clin Biochem 34:125–129PubMedCrossRef Kose K, Yazici C, Assioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet’s disease. Clin Biochem 34:125–129PubMedCrossRef
29.
go back to reference Dincer Y, Alademir Z, Hamuryudan V, Fresko I, Akcay T (2002) Superoxide dismutase activity and glutathione system in erythrocytes of men with Behcet’s disease. Tohoku J Exp Med 198:191–195PubMedCrossRef Dincer Y, Alademir Z, Hamuryudan V, Fresko I, Akcay T (2002) Superoxide dismutase activity and glutathione system in erythrocytes of men with Behcet’s disease. Tohoku J Exp Med 198:191–195PubMedCrossRef
30.
go back to reference Memisogullari R, Taysi S, Bakan E, Capoglu I (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 21:291–296PubMedCrossRef Memisogullari R, Taysi S, Bakan E, Capoglu I (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 21:291–296PubMedCrossRef
31.
go back to reference Taysi S, Akcay F, Uslu C, Dogru Y, Gulcin I (2003) Trace elements and some extracellular antioxidant proteins levels in serum of patients with laryngeal cancer. Biol Trace Elem Res 91:11–18PubMedCrossRef Taysi S, Akcay F, Uslu C, Dogru Y, Gulcin I (2003) Trace elements and some extracellular antioxidant proteins levels in serum of patients with laryngeal cancer. Biol Trace Elem Res 91:11–18PubMedCrossRef
Metadata
Title
Oxidant/antioxidant status in men with Behçet’s disease
Authors
Seyithan Taysi
Berna Demircan
Necmettın Akdeniz
Mustafa Atasoy
Refik Ali Sari
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0513-x

Other articles of this Issue 3/2007

Clinical Rheumatology 3/2007 Go to the issue

Acknowledgement to Reviewers

Acknowledgement to Reviewers

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine